摘要
目的:研究针对K-ras突变小分子NSC-741909是否可特异性杀伤吉非替尼原发耐药细胞,并对活性氧(reactive oxygenspecies,ROS)在其中的作用进行探讨。方法:选取H322(K-ras野生)及A549(K-ras突变)人源非小细胞肺癌细胞系,观察吉非替尼对不同细胞系生长的影响;NSC-741909作用于吉非替尼耐药细胞,观察细胞增殖与凋亡的变化;DCFH-DA荧光探针标记细胞内ROS,FCM检测细胞内ROS水平的变化,Western blot检测细胞内JNK通路蛋白变化。结果:K-ras突变型细胞对吉非替尼原发耐药,但NSC-741909可使这种原发耐药细胞出现凋亡;细胞内产生ROS,p-JNK表达增加而总JNK无改变,MKP1表达受抑制。结论:针对K-ras突变的小分子NSC-741909可使吉非替尼耐药细胞产生凋亡,NSC-741909通过使细胞内产生ROS持续激活JNK通路,是其导致吉非替尼耐药细胞凋亡的可能机制之一。
Objective: To investigate the specific cytotoxicity of the anticancer agent NSC-741909 on the growth of a non-small cell lung cancer ( NSCLC ) cell line primarily resistant to gefitinib, and to explore the role of reactive oxygen species ( ROS ) in the process. Methods: Two NSCLC cell lines with different sensitivities to gefitinib were selected, and the effects of gefltinib on cell growth, and induction of apoptosis induction by NSC-741909 were observed. The fluorescent probe 2',7'-dichlorofluorescein diacetate ( DCFH-DA ) was used to label the intracellular ROS and the intracellular fluorescence intensity was detected using flow cytometry ( FCM ). Jurl N-terminal kinase ( JNK ) activation was detected using Western blot analysis. Results: NSC-741909 induced the apoptosis of the NSCLC cells primarily resistant to gefltinib. ROS was detected in this cell line. There was an increase in P-JNK expression, whereas the total JNK protein expression remained unchanged. The MKP1 expression was suppressed. Conclusion: NSC-741909, which suppresses mutant K-Ras expression, induced the apoptosis of NSCLC cells that are primarily resistant to gefltinib. This inhibition was mediated by increased ROS production and subsequent JNK activation.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2011年第11期634-637,共4页
Chinese Journal of Clinical Oncology
基金
天津市自然科学基金(编号:10JCYBJC25600)资助~~
关键词
非小细胞肺癌
吉非替尼耐药
活性氧
NSCLC
Gefitinib primary resistance
Reactive oxygen species